[go: up one dir, main page]

CL2018001961A1 - Procedimiento de preparación de derivados de metil-penam (divisional solicitud 201602880) - Google Patents

Procedimiento de preparación de derivados de metil-penam (divisional solicitud 201602880)

Info

Publication number
CL2018001961A1
CL2018001961A1 CL2018001961A CL2018001961A CL2018001961A1 CL 2018001961 A1 CL2018001961 A1 CL 2018001961A1 CL 2018001961 A CL2018001961 A CL 2018001961A CL 2018001961 A CL2018001961 A CL 2018001961A CL 2018001961 A1 CL2018001961 A1 CL 2018001961A1
Authority
CL
Chile
Prior art keywords
methyl
divisional application
preparation procedure
rent
penam derivatives
Prior art date
Application number
CL2018001961A
Other languages
English (en)
Inventor
Andrea Faini
Marco Forzatti
Giovanni Fogliato
Stefano Biondi
Original Assignee
Allecra Therapeutics Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allecra Therapeutics Sas filed Critical Allecra Therapeutics Sas
Publication of CL2018001961A1 publication Critical patent/CL2018001961A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1896Compounds having one or more Si-O-acyl linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/87Compounds being unsubstituted in position 3 or with substituents other than only two methyl radicals attached in position 3, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Feed For Specific Animals (AREA)

Abstract

UN MÉTODO DE FORMACIÓN DE UN COMPUESTO DE FÓRMULA (IV), EN DONDE R1 EN CADA OCURRENCIA SE SELECCIONA INDEPENDIENTEMENTE DE H, HALÓGENO, AMINO, ALQUILO DE C1-5, ALQUENILO DE C1-5 Y ALQUINILO DE C1-5; R2 EN CADA OCURRENCIA SE SELECCIONA INDEPENDIENTEMENTE DE H, HALÓGENO, AMINO, ALQUILO DE C1-5, ALQUENILO DE C1-5 Y ALQUINILO DE C1-5; Y R4 ES ALQUILO DE C1-5; MÉTODO QUE COMPRENDE HACER REACCIONAR UN COMPUESTO DE FÓRMULA (III) CON UNA SAL DE 2-ETILHEXANOATO, EN DONDE X- ES UN ANIÓN Y CADA R3 SE SELECCIONA INDEPENDIENTEMENTE DEL GRUPO QUE CONSISTE EN HIDROCARBILO DE C1-10 Y ALCOXI DE C1-5.
CL2018001961A 2014-05-15 2018-07-19 Procedimiento de preparación de derivados de metil-penam (divisional solicitud 201602880) CL2018001961A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1408649.0A GB201408649D0 (en) 2014-05-15 2014-05-15 Method

Publications (1)

Publication Number Publication Date
CL2018001961A1 true CL2018001961A1 (es) 2018-08-31

Family

ID=51134924

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2016002880A CL2016002880A1 (es) 2014-05-15 2016-11-11 Metodo
CL2018001961A CL2018001961A1 (es) 2014-05-15 2018-07-19 Procedimiento de preparación de derivados de metil-penam (divisional solicitud 201602880)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2016002880A CL2016002880A1 (es) 2014-05-15 2016-11-11 Metodo

Country Status (29)

Country Link
US (1) US9963465B2 (es)
EP (3) EP3231806B1 (es)
JP (1) JP6613303B2 (es)
KR (1) KR102329186B1 (es)
CN (1) CN106459086B (es)
AU (1) AU2015261416B2 (es)
BR (1) BR112016026074B1 (es)
CA (1) CA2945900C (es)
CL (2) CL2016002880A1 (es)
CR (1) CR20160580A (es)
CY (2) CY1120957T1 (es)
DK (2) DK3143028T3 (es)
EA (2) EA033494B1 (es)
EC (1) ECSP16085143A (es)
ES (2) ES2725675T3 (es)
GB (1) GB201408649D0 (es)
HR (2) HRP20182065T1 (es)
HU (1) HUE044511T2 (es)
IL (1) IL248834B (es)
LT (2) LT3231806T (es)
MX (1) MX378875B (es)
PE (1) PE20161433A1 (es)
PL (2) PL3143028T3 (es)
PT (2) PT3231806T (es)
RS (2) RS58430B1 (es)
SG (1) SG11201609494YA (es)
SI (2) SI3231806T1 (es)
TR (1) TR201906867T4 (es)
WO (1) WO2015173378A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201319776D0 (en) * 2013-11-08 2013-12-25 Allecra Therapeutics Sas Compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1319776A (en) 1969-07-15 1973-06-06 Yorkshire Chemicals Ltd Basic dyes
PL2046802T3 (pl) 2006-07-12 2014-01-31 Allecra Therapeutics Gmbh 2-podstawione pochodne metylopenemu
MX353447B (es) 2010-11-25 2018-01-11 Allecra Therapeutics Gmbh Compuestos y su uso.
KR20120067257A (ko) * 2010-12-15 2012-06-25 서강대학교산학협력단 3-메틸-1,4-치환된 1,2,3-트라이아졸륨 기반의 이온성 액체 및 그의 제조방법과 응용

Also Published As

Publication number Publication date
BR112016026074B1 (pt) 2023-01-03
DK3231806T3 (da) 2019-05-20
SG11201609494YA (en) 2016-12-29
PT3143028T (pt) 2018-12-17
EA033494B1 (ru) 2019-10-31
BR112016026074A8 (pt) 2021-03-30
EP3143028A2 (en) 2017-03-22
CL2016002880A1 (es) 2017-06-16
CA2945900A1 (en) 2015-11-19
ECSP16085143A (es) 2017-05-31
CN106459086A (zh) 2017-02-22
RS58430B1 (sr) 2019-04-30
US20170101421A1 (en) 2017-04-13
GB201408649D0 (en) 2014-07-02
EA201991629A2 (ru) 2019-12-30
JP2017515907A (ja) 2017-06-15
WO2015173378A2 (en) 2015-11-19
MX2016014644A (es) 2017-02-23
CN106459086B (zh) 2018-11-13
CY1120957T1 (el) 2019-12-11
KR102329186B1 (ko) 2021-11-22
WO2015173378A3 (en) 2016-01-14
AU2015261416A1 (en) 2016-11-10
TR201906867T4 (tr) 2019-05-21
CA2945900C (en) 2023-01-24
HUE044511T2 (hu) 2019-10-28
MX378875B (es) 2025-03-11
EA201692306A1 (ru) 2017-05-31
EP3441395A1 (en) 2019-02-13
EA201991629A3 (ru) 2020-02-28
HRP20182065T1 (hr) 2019-02-08
HRP20190830T1 (hr) 2019-06-28
SI3143028T1 (sl) 2019-01-31
IL248834B (en) 2019-05-30
SI3231806T1 (sl) 2019-06-28
ES2725675T3 (es) 2019-09-26
CY1121756T1 (el) 2020-07-31
ES2699644T3 (es) 2019-02-12
PT3231806T (pt) 2019-05-30
DK3143028T3 (da) 2019-01-02
EP3231806B1 (en) 2019-02-13
LT3231806T (lt) 2019-05-27
EP3143028B1 (en) 2018-09-26
JP6613303B2 (ja) 2019-11-27
PL3231806T3 (pl) 2019-08-30
CR20160580A (es) 2017-05-09
EP3231806A1 (en) 2017-10-18
LT3143028T (lt) 2018-12-27
PE20161433A1 (es) 2017-01-18
US9963465B2 (en) 2018-05-08
PL3143028T3 (pl) 2019-04-30
KR20170002466A (ko) 2017-01-06
RS58748B1 (sr) 2019-06-28
NZ725121A (en) 2023-09-29
IL248834A0 (en) 2017-01-31
AU2015261416B2 (en) 2019-07-11

Similar Documents

Publication Publication Date Title
ECSP18053634A (es) Nuevos derivados de amonio, un proceso para su preparación y composiciones farmacéuticas que los contienen
EA201991412A1 (ru) Ингибиторы поли(адф-рибоза)полимеразы (parp)
EA201892838A1 (ru) Новые пиперидинильные производные, способ их получения и фармацевтические композиции, содержащие их
EA201890124A1 (ru) Новые гидроксикислотные производные, способ их получения и фармацевтические композиции, содержащие их
EA201890126A1 (ru) Новые бициклические производные, способ их получения и фармацевтические композиции, содержащие их
DOP2015000251A (es) Derivados de naftiridina utiles como antagonistas de la alfa-v-beta-6 integrina
EA201890123A1 (ru) Новые аминокислотные производные, способ их получения и фармацевтические композиции, содержащие их
BR112017027414A2 (pt) Derivados hidroxiéster, processo para prepará- los e composições farmacêuticas os contendo
EA201791692A1 (ru) 4H-ПИРРОЛО[3,2-c]ПИРИДИН-4-ОНОВЫЕ ПРОИЗВОДНЫЕ
MX391539B (es) Proceso de compuesto antifungico.
BR112016008468A2 (pt) Composto de fórmula, composição farmacêutica, composto, uso de um composto e método para o tratamento ou melhora de câncer
EA201600091A1 (ru) 4-членные кольцевые карбоксамиды, применяемые в качестве нематоцидов
EA201790395A1 (ru) Производные аминотриазина, подходящие для применения в качестве соединений-ингибиторов tank-связывающей киназы
MX377816B (es) Derivados de piridil cetona, metodo de preparacion de los mismos, y la aplicacion farmaceutica de los mismos.
CO2017001178A2 (es) Derivado de piridona que tiene un grupo tetrahidropiranil metilo
BR112017026452A2 (pt) moduladores de receptores nucleares
PH12020550905A1 (en) Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives
EA201890898A1 (ru) Новые соединения и конъюгаты криптофицина, их получение и их терапевтическое применение
EA201691648A1 (ru) Способ получения противогрибковых соединений
AR102767A1 (es) Inhibidores de ezh2
BR112019025028A2 (pt) Método para preparar um composto.
EA201790496A1 (ru) Соединения 1-алкил-6-оксо-1,6-дигидропиридин-3-ила и применение в качестве модуляторов sgrm
EA201790655A1 (ru) Новые активаторы растворимой гуанилатциклазы и их применение
NO20181480A1 (en) Encapsulated production chemicals
CR20180181A (es) Nuevos derivados de imidazol[4,5-b]piridina, un proceso para su preparación y composiciones farmacéuticas que los contienen